共 6 条
[1]
Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. TF Hiemstra,M Walsh,A Mahr,CO Savage,K Groot,L Harper. The Journal of The American Medical Association . 2010
[2]
Rituximab versus cyclophos-phamide in ANCA-associated renal vasculitis. Jones RB,Tervaert JW,Hauser T,et al. The New England Journal of Medicine . 2010
[3]
Rituximab versus cyclophos-phamide for ANCA-associated vasculitis. Stone JH,Merkel PA,Spiera R,et al. The New England Journal of Medicine . 2010
[4]
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. Jayne D,Rasmussen N,Andrassy K,et al. New England Journal of Medicine, The . 2003
[5]
Azathioprine or metho-trexate maintenance for ANCA-associated vasculitis. Pagnoux C,Mahr A,Hamidou MA,et al. The New England Journal of Medicine . 2008
[6]
Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. DR Jayne,G Gaskin,N Rasmussen,D Abramowicz,F Ferrario,L Guillevin,E Mirapeix,CO Savage,RA Sinico,CA Stegeman,KW Westman,FJ Woude,de Lind van Wijngaarden RA,CD Pusey. Journal of the American Society of Nephrology . 2007